Atazanavir: its role in HIV treatment

Efficacy and Safety of Atazanavir, With or Without Ritonavir, as Part of Once-Daily Highly Active Antiretroviral Therapy Regimens in Antiretroviral-Naive Patients

(2009) D. R (Niel) Malan et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Decrease of Atazanavir and Lopinavir Plasma Concentrations in a Boosted Double Human Immunodeficiency Virus Protease Inhibitor Salvage Regimen

(2008) N. von Hentig et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In Vitro Phenotypic Susceptibility of Human Immunodeficiency Virus Type 2 Clinical Isolates to Protease Inhibitors

(2008) D. Desbois et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Inhibition of HIV-2 Protease by HIV-1 Protease Inhibitors in Clinical Use

(2008) Evan T. Brower et al.   Chemical Biology & Drug Design

HIV protease inhibitors that block GLUT4 precipitate acute, decompensated heart failure in a mouse model of dilated cardiomyopathy

(2008) Paul W. Hruz et al.   FASEB JOURNAL

Cardiovascular risk score change in HIV-1-infected patients switched to an atazanavir-based combination antiretroviral regimen

(2008) M Colafigli et al.   HIV MEDICINE

Liver toxicity of antiretroviral combinations including atazanavir/ritonavir in patients co-infected with HIV and hepatitis viruses: impact of pre-existing liver fibrosis

(2008) J. A. Pineda et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Acute renal failure due to bilateral ureteral stone impaction in an HIV-positive patient

(2008) Yoji Moriyama et al.   UROLOGICAL RESEARCH

Fosamprenavir or atazanavir once daily boosted with ritonavir 100mg, plus tenofovir/emtricitabine, for the initial treatment of HIV infection: 48-week results of ALERT

(2008) Kimberly Y Smith et al.   AIDS Research and Therapy